アジア太平洋地域の脳神経外科市場 – 2029年までの業界動向と予測

アジア太平洋地域の脳神経外科市場の分析と洞察

医療における技術革新とは、臨床診療に変化をもたらす新しい技術の導入と定義できます。脳神経外科は特に技術集約的な外科分野であり、新しい技術は脳神経外科手術技術の大きな進歩の多くに先行しています。現在は、手術中の合併症の可能性を減らすことができる低侵襲性デバイスの開発に重点が置かれています。低侵襲性技術の導入により、医師は電動工具、神経血管塞栓装置、ガンマナイフなどの放射線手術システムなど、高度に専門化された外科器具を使用しています。

さらに、規制基準の強化や神経疾患の発生率の増加など、一連の新しい要因により、高度な治療プロトコルの採用が増加し、そのような治療法がより広く利用可能になるという想定が生まれました。これにより、業界と政府のゼロ逸脱の要求が高まり、脳神経外科サービスの需要が高まりました。業界間の提携と協力の増加は、脳神経外科市場を押し上げると予想される主な要因です。ただし、神経内視鏡機器と手順にかかるコストの上昇と、訓練を受けた専門家の不足により、予測期間中の市場の成長が抑制される可能性があります。

Data Bridge Market Research の分析によると、アジア太平洋地域の脳神経外科市場は、予測期間中に 15.7% の CAGR で成長し、2029 年までに 35 億 3,544 万米ドルに達する見込みです。アジア太平洋地域では患者数が増加しているため、「製品タイプ」が市場で最大のタイプ セグメントを占めています。この市場レポートでは、価格分析、特許分析、技術進歩についても詳細に取り上げています。

Asia-Pacific Neurosurgery Market Definition

The neurological conditions include dementia, headache disorders, neuro-infections, and multiple sclerosis, traumatic brain injuries, pain associated with neurological disorders, neurological disorders associated with malnutrition, stroke, epilepsy, and Parkinson's disease. These disorders are fatal and cannot be cured by therapeutics. Some of the neurosurgery devices are neuro-endoscopes, stereotactic systems, catheters, pacemakers, single- and dual-chamber defibrillators, and implantable cardioverter defibrillators among others, that are used in a variety of neurosurgical procedures. Neurosurgery aids in the diagnosis of patients who have brain tumors, spinal cord injuries brought by accidents, neck and back discomfort, and abnormal spinal fluid movement. Around 7 to 10 million people worldwide suffer from Parkinson's disease. Neurological illness is one of the main causes of morbidity and disability worldwide. During the forecast period, technological developments in neurosurgery are anticipated to drive the market. The rise in incidences and prevalence of neurological conditions within the population and the advantage of neurosurgery over other conventional surgeries are expected to boost the growth of the neurosurgery market across the globe. In addition, advances in neurological surgeries such as 3-dimension reconstruction for brain tumor surgery, X-knife radiosurgery for brain lesions, MRI for brain tumors, and surgery under local anesthesia for brain tumors are anticipated to provide lucrative opportunities for the growth of the neurosurgery market.

Asia-Pacific Neurosurgery Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

• Technological advancement in neurosurgery

Since the beginning of modern neurosurgery, technological advancements have paved the way for a more thorough and enhanced understanding of cerebral form and function to more effectively treat complex pathologies affecting patients. Technological advancements brought a transition from conventional equipment toward energy-efficient equipment based on novel technology. Several cutting-edge techniques help neurosurgeries quite easily. Neurosurgery is a particularly technologically intensive surgical discipline, and new technologies have preceded many of the major advances in operative neurosurgical techniques. Image guidance and neuromodulation devices demonstrated a highly correlated rapid rise in patents and publications, suggesting they are areas of technology expansion which is expected to boost the market growth.

With the growth in the prevalence of neurological conditions, the demand for neurosurgery is also increasing. The market is expected to grow in the forecast period.

Moreover, the adoption of endoscopic techniques' is a significant market advancement. Additionally, recovery time is shorter in neurosurgeries. Thus, all these factors are expected to act as drivers for market growth.

• Rising Prevalence of Neurological Conditions

The World Health Organization (WHO) focuses on research in areas that are important for public health promotion. Recently, WHO has been particularly interested in frequent and disabling neurological disorders with a high burden on the world. Neurological disorders occur among all age groups and different geographical regions. They significantly contribute to morbidity and mortality around the world. The neurological burden of disease is expected to grow exponentially in low- and middle-income countries (LMICs) in the next decade.

The rising prevalence of neurological conditions such as transnasal hemorrhage, intracerebral hemorrhage (ICH), traumatic brain injury, chronic pain, depression, and Parkinson's is expected to drive market growth.

Thus, increasing neurological disorders such as transnasal hemorrhage and intracerebral hemorrhage (ICH) are fueling market growth. Neurological conditions have become a major public health crisis which is expected to boost the growth of the Asia-Pacific neurosurgery market.

Restraint

• The high cost associated with neurosurgeries and equipment

A significant increase in the cost of neurosurgical products has been observed in recent years, which end users such as hospitals and neurosurgical centers have to incur. Products such as neurovascular embolization devices, neurovascular coiling devices, and neuroendoscopes are quite costly. Manufacturers are also giving more resources to research and development to introduce cost-effective and advanced technology. Some complex neurosurgeries require extensive time as well as effort, and they are also quite risky. These complex procedures need advanced techniques and skills, and because of this, the cost of equipment and neurosurgeries increases. The maintenance of such facilities and continuous requirement of power supply add up to the cost of the surgeries. Decompressive craniectomy for traumatic brain injury (TBI) is an expensive procedure that is also associated with high morbidity and mortality.

The cost associated with neurosurgery procedures is quite high, which is expected to act as a restrain for the market growth.

Opportunity

• Rising awareness about neurological disorders

With the rising Asia-Pacific population, a large portion of the geriatric section is getting affected with neurological disorders such as epilepsy, Parkinson's disease, stroke, brain tumor, dementia, and multiple sclerosis, among others. So, understanding neurological disorders is important, and awareness about neurological conditions can lead to seeking medical attention, which results in proper diagnosis and effective treatment. All neurological disorders account for 82.8%. The massive fold increases the burden of neurological disorders that can be attributed to a lack of awareness about neurological disorders and treatment, which lead to delayed detection, and lack of access to quality healthcare and rehabilitation centers. Rising healthcare programs and increasing funding from governments and public healthcare agencies help reduce the burden of neurological disorders and develop neurological products that act in favor of market growth.

Rising awareness about neurological disorders is beneficial for the neurosurgery market. In most regions, many governmental and non-governmental are carry some awareness programs for the early detection of neurological conditions.

Challenge

• Alternative Treatments For Neurological Disease

Drug therapies are the first line of treatment for the treatment of neurological conditions. Neurosurgical procedures are opted only if non-surgical treatments are not effective. Complementary and alternative treatments are increasingly employed to supplement neurosurgical treatment in neurosurgery. This includes acupuncture, naturopathic medicine, chiropractic treatment, and ayurvedic medicine among others. More recently, doctors have become increasingly receptive to the use of alternative treatments, and scientific studies on the safety and effectiveness of complementary and alternative options are taken through the national institutes of health, which may act as a challenge to the growth of the neurosurgery market.

Thus, alternative treatment options are expected to offer significant challenges for the Asia-Pacific neurosurgical market. 

Post-COVID-19 Impact on Asia-Pacific Neurosurgery Market

The COVID-19 outbreak had a drastic effect on Asia-Pacific healthcare, with China amongst the countries most severely impacted. The pandemic has had a negative impact on the neurosurgery market growth on account of the temporary halt in research activities in this field, coupled with the low influx of patients in hospitals and diagnostic centers. Moreover, the impact of COVID-19 pandemic on neurosurgical products delivery is challenging the neurosurgeons for getting delivery of surgical products.

Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launches, and strategic partnerships to improve the technology in the neurosurgery market.

Recent Developments

• In March 2022, Medtronic, an Asia-Pacific leader in healthcare technology, announced their first patient implants in the TITAN 2 pivotal study that evaluated the safety and efficacy of Medtronic's investigational implantable tibial neuromodulation (TNM) device in people with overactive bladder (OAB). Implantable TNM has the potential to give relief to millions who suffer from bladder incontinence through a new approach that provides greater convenience and more options for physicians and patients. This will help the company to evaluate the safety and efficacy of its products
• In April 2022, Abbott announced that it had launched an upgraded version of its NeuroSphere myPath digital health app with enhanced functionality that will help doctors more closely track their patients as they trial Abbott neurostimulation devices to address their chronic pain. This upgrade is part of Abbott's commitment to connected care technology and is intended to put people in control of their health and facilitate better communication with their doctors. This has helped the company to enhance its product use by launching the app

Asia-Pacific Neurosurgery Market Scope

The neurosurgery market is segmented into product type, application, age group, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

By Product Type

• Neurosurgery devices
• Neurosurgery software
• Consumables

On the basis of product type, the neurosurgery market is segmented into neurosurgery devices, neurosurgery software, and consumables.

By Application

• Aneurysms
• Arteriovenous malformation (AVM)
• Brain tumors
• Carotid artery blockage/stenosis
• Cerebrovascular surgery
• Cortical mapping
• Epilepsy
• Functional neurosurgery
• Intraoperative angiography
• Parkinson's disease and tremors
• Peripheral nerve surgery
• Pituitary tumors
• Radiosurgery
• Skull base surgery
• Spine surgery
• Stereotactic neurosurgery
• Trauma surgery
• Trigeminal neuralgia
• Others

On the basis of application, the neurosurgery market is segmented into aneurysms, arteriovenous malformation (AVM), brain tumors, carotid artery blockage/stenosis, cerebrovascular surgery, cortical mapping, epilepsy, functional neurosurgery, intraoperative angiography, Parkinson's disease and tremors, peripheral nerve surgery, pituitary tumors, radiosurgery, skull base surgery, spine surgery, stereotactic neurosurgery, trauma surgery, trigeminal neuralgia, others.

By Age Group

• Pediatric
• Adult
• Geriatric

On the basis of end user, the neurosurgery market is segmented into pediatric, adult, and geriatric.

By End User

• Hospitals
• Research centers
• Neurosurgery centers
• Ambulatory surgical centers (ASCS)
• Others

On the basis of end user, the neurosurgery market is segmented into hospitals, neurosurgery centers, research centers, ambulatory surgical centers, and others

By Distribution Channel

• 直接入札
• サードパーティの販売業者
• その他

流通チャネルに基づいて、アジア太平洋の脳神経外科市場は、直接入札、サードパーティの販売代理店、その他に分類されます。

アジア太平洋地域の脳神経外科市場の地域分析/洞察

アジア太平洋地域の脳神経外科市場が分析され、製品タイプ、用途、年齢層、エンドユーザー、流通チャネル別に市場規模の情報が提供されます。

この市場レポートで取り上げられている国は、中国、日本、インド、韓国、シンガポール、タイ、マレーシア、オーストラリア、フィリピン、インドネシア、およびその他のアジア太平洋諸国です。

2022年には、医療費の増加により、アジア太平洋地域が3番目に優勢な地域になると予想されています。中国は、脳神経外科機器の技術的進歩の高まりにより、アジア太平洋地域の脳神経外科市場を支配し、成長すると予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、アジア太平洋ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。

競争環境とアジア太平洋地域の脳神経外科市場シェア分析

アジア太平洋の脳神経外科市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、アジア太平洋の脳神経外科市場への会社の重点にのみ関連しています。

アジア太平洋地域の脳神経外科市場で活動している主要企業としては、メドトロニック、アボット、ボストン・サイエンティフィック・コーポレーション、エレクタ、ALEVA NEUROTHERAPEUTICS、町田内視鏡株式会社、ブレインラボAG、adeor medical AG、LivaNova PLC、B. Braun SE、Optofine Instruments Pvt. Ltd.、ワラビーメディカル、テルモメディカルコーポレーション、NEVRO CORP.、Integra LifeSciences、Stryker、Penumbra, Inc.、KARL STORZ SE & Co. KG、Renishaw plc、Inomed Medizintechnik GmbH、ANT Neuro、Leica Microsystemsなどが挙げられます。

調査方法: アジア太平洋地域の脳神経外科市場

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。市場データは、市場統計モデルとコヒーレント モデルを使用して分析および推定されます。さらに、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数の市場への影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。これとは別に、データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、企業市場シェア分析、測定基準、アジア太平洋と地域、ベンダー シェア分析が含まれます。さらに問い合わせる場合は、アナリストへの電話をリクエストしてください。

SKU-69199